# EDGAR Filing Document

**Accession Number:** 0000896264
**File Stem:** 0000896264-26-000042
**Filing Date:** 2026-6
**Character Count:** 29799
**Document Hash:** 1454a72242a566631a2f199001217884
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000896264-26-000042.hdr.sgml**: 20260615

**ACCESSION NUMBER**: 0000896264-26-000042

**CONFORMED SUBMISSION TYPE**: 11-K

**PUBLIC DOCUMENT COUNT**: 31

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260615

**DATE AS OF CHANGE**: 20260612

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** USANA HEALTH SCIENCES INC
- **CENTRAL INDEX KEY:** 0000896264
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 870500306
- **STATE OF INCORPORATION:** UT
- **FISCAL YEAR END:** 0103

**FILING VALUES:**
- **FORM TYPE:** 11-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35024
- **FILM NUMBER:** 261088714

**BUSINESS ADDRESS:**
- **STREET 1:** 3838 WEST PARKWAY BLVD.
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84120-6336
- **BUSINESS PHONE:** 8019547100

**MAIL ADDRESS:**
- **STREET 1:** 3838 WEST PARKWAY BLVD.
- **STREET 2:** 3838 WEST PARKWAY BLVD.
- **CITY:** SALT LAKE CITY
- **STATE:** UT
- **ZIP:** 84120-6336

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** USANA INC
- **DATE OF NAME CHANGE:** 19930125

?xml version='1.0' encoding='ASCII'? usna-20260612

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 11-K**

☒ **ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the fiscal year ended December 31, 2025** 

**or**

---

| | |
|:---|:---|
| ☐ | **TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| | **For the transition period from ___________ to ____________** |

---

**Commission file number: 001-35024**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. Full title of the plan and the address of the plan, if different from that of the issuer named below:

**USANA HEALTH SCIENCES 401(k) PLAN**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

**USANA HEALTH SCIENCES, INC.**

**3838 West Parkway Blvd.**

**Salt Lake City, Utah 84120**

------

**USANA HEALTH SCIENCES 401(k) PLAN**

**FORM 11-K**

**For the Year Ended December 31, 2025**

**INDEX** 

---

| | |
|:---|:---|
| | **<u>Page</u>** |
| <u>[Report of Independent Registered Public Accounting Firm](#ibcb420541dda49faa3d6ddaedcefe316_4)</u> | <u>[1](#ibcb420541dda49faa3d6ddaedcefe316_4)</u> |
| <u>[Financial Statements:](#ibcb420541dda49faa3d6ddaedcefe316_7)</u> |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Statements of Net Assets Available for Benefits](#ibcb420541dda49faa3d6ddaedcefe316_10)</u> | <u>[2](#ibcb420541dda49faa3d6ddaedcefe316_10)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>[Statement of Changes in Net Assets Available for Benefits](#ibcb420541dda49faa3d6ddaedcefe316_13)</u> | <u>[3](#ibcb420541dda49faa3d6ddaedcefe316_13)</u> |
| <u>[Notes to Financial Statements](#ibcb420541dda49faa3d6ddaedcefe316_16)</u> | <u>[4](#ibcb420541dda49faa3d6ddaedcefe316_16)</u> |
| <u>[Schedule of Assets (Held at End of Year)\*](#ibcb420541dda49faa3d6ddaedcefe316_37)</u> | <u>[8](#ibcb420541dda49faa3d6ddaedcefe316_37)</u> |
| <u>[Exhibit](#ibcb420541dda49faa3d6ddaedcefe316_40)</u> | <u>[9](#ibcb420541dda49faa3d6ddaedcefe316_40)</u> |
| <u>[Signature](#ibcb420541dda49faa3d6ddaedcefe316_43)</u> | <u>[10](#ibcb420541dda49faa3d6ddaedcefe316_43)</u> |

---

\* Other supplementary schedules required by section 2520.103-10 of the Department of Labor's Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974 have been omitted because they are not applicable.

------

**<u>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u>**

To the Plan Administrators and Plan Participants of

USANA Health Sciences 401(k) Plan

**Opinion on the Financial Statements**

We have audited the accompanying statements of net assets available for benefits of the USANA Health Sciences 401(k) Plan (the Plan) as of December 31, 2025 and 2024, and the related statement of changes in net assets available for benefits for the year ended December 31, 2025, and the related notes to financial statements (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan as of December 31, 2025 and 2024, and the changes in net assets available for benefits for the year ended December 31, 2025, in conformity with accounting principles generally accepted in the United States of America.

**Basis for Opinion**

These financial statements are the responsibility of the Plan's management. Our responsibility is to express an opinion on the Plan's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Plan's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

**Supplemental Information**

The supplemental information contained in the schedule of assets (held at end of year) has been subjected to audit procedures performed in conjunction with the audit of the Plan's financial statements. The supplemental information is the responsibility of the Plan's management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor's Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.

/s/ Tanner LLP

We have served as the Plan's auditor since 2004.

Salt Lake City, Utah

June 12, 2026

&nbsp;&nbsp;&nbsp;&nbsp;

------

**USANA HEALTH SCIENCES 401(k) PLAN**

**Statements of Net Assets Available for Benefits**

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2025** | **2024** |
| Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Investments, at fair value: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mutual funds | $127589410 | $115197895 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;USANA Health Sciences, Inc. Stock Fund | 1318480 | 2462308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collective investment fund | 7305763 | 6264482 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total investments | 136213653 | 123924685 |
| &nbsp;&nbsp;&nbsp;Receivables: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes receivable from participants | 2284606 | 2400566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total receivables | 2284606 | 2400566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net assets available for benefits | $138498259 | $126325251 |

---

The accompanying notes are an integral part of these statements.

------

**USANA HEALTH SCIENCES 401(k) PLAN** 

Statement of Changes in Net Assets Available for Benefits

Year Ended December 31, 2025

---

| | |
|:---|:---|
| Additions: |  |
| &nbsp;&nbsp;Investment income: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net appreciation in fair value of investments | $13029921 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and dividends | 5735711 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Investment income | 18765632 |
| &nbsp;&nbsp;Interest on notes receivable from participants | 188179 |
| &nbsp;&nbsp;Contributions: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Participants | 6300713 |
| &nbsp;&nbsp;&nbsp;&nbsp;Employer | 2312143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Rollovers | 1163133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total contributions | 9775989 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total additions | 28729800 |
| Deductions: |  |
| &nbsp;&nbsp;Benefits paid to participants | (16338676) |
| &nbsp;&nbsp;Administrative expenses | (218116) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total deductions | (16556792) |
| Increase in net assets available for benefits | 12173008 |
| Net assets available for benefits: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of the year | 126325251 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of the year | $138498259 |

---

The accompanying notes are an integral part of these statements.

------

**USANA HEALTH SCIENCES 401(k) PLAN**

**NOTES TO FINANCIAL STATEMENTS**

**NOTE A** – **DESCRIPTION OF THE PLAN**

The following description of the USANA Health Sciences 401(k) Plan (the "Plan") provides only general information. Participants and other financial statement users should refer to the Plan document, as amended, and summary plan description for a more complete description of the Plan's provisions.

1. <u>General</u>

The Plan is a defined contribution plan covering substantially all United States non-union employees of USANA Health Sciences, Inc. (collectively, the "Company" or the "Employer") who have completed one month of service and are age 18 or older. The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 ("ERISA"), as amended, and permits traditional 401(k) deferrals (pre-tax) as well as Roth 401(k) deferrals (after-tax).

The trustee for the 2025 and 2024 Plan years is Fidelity Management Trust Company ("Fidelity" or "Trustee") and the recordkeeping functions were performed by Fidelity Workplace Services, LLC.

On December 29, 2022, the Setting Every Community Up for Retirement Enhancement Act 2.0 ("SECURE 2.0") was signed into law, continuing the themes and reforms that began with the 2019 CARES Act. Many of the provisions of SECURE 2.0 became effective in 2024, including mandatory and optional provisions impacting defined contribution plans. The Plan has adopted all of the applicable mandatory provisions, including increasing the age at which required minimum distributions start, eliminating the required minimum distributions for Roth 401(k) accounts, and new spousal beneficiary rules.

2. <u>Contributions</u>

Each year participants may elect to contribute up to 75 percent of their annual compensation subject to certain limits as defined in the Plan. Participant contributions are limited by the Internal Revenue Code, which established a maximum contribution of $23,500 ($31,000 for participants age 50 or older and $34,750 for participants age 60 through 63 during 2025) for the year ended December 31, 2025. Participants may elect to make pre-tax contributions and/or after-tax elective contributions into their accounts. Participants may also contribute rollover amounts representing distributions from certain other defined benefit or defined contribution plans. Under the safe harbor and certain other provisions of the Plan, eligible employees who have not made an affirmative election to defer or not defer will have deferrals withheld in the amount of 6 percent of their compensation, to be invested in the appropriate target date retirement fund. Participants may direct their investments into one or more of the investment options offered by the Plan, with no more than 25 percent of their investment allocations directed into shares of the USANA Health Sciences, Inc. Stock Fund ("Stock Fund").

The Company provides a matching contribution equal to 100 percent of the first 1 percent of a participant's compensation that is contributed as an elective deferral by the participant, and 50 percent of elective deferrals between one and 6 percent of the participant's compensation. The Company's Board of Directors may also authorize additional contributions to the Plan. No additional contributions were authorized during the year ended December 31, 2025.

3. <u>Participant accounts</u>

Self-directed individual investment accounts are maintained for each Plan participant. Each participant's account is adjusted for the participant's contributions and allocations of (a) the Company's contributions, (b) investment gains or losses, (c) interest and dividends, and (d) administrative expenses. The allocation of the Company's discretionary contributions and forfeitures is based on each participant's contribution, as defined by the Plan. The benefit to which a participant is entitled is the benefit that can be provided from the participant's vested account.

4. <u>Vesting</u>

Participants are fully vested in their voluntary contributions, including any net investment income on those contributions. The Company's matching contributions fully vest at the end of two years of service. Non-elective employer contributions vest 25% at the end of each year and are fully vested after four years of service.

------

5. <u>Notes receivable from participants</u>

A participant may borrow a minimum of $1,000 through up to a maximum of three loans, that in the aggregate are equal to the lesser of $50,000 or 50 percent of his or her vested account balance. Loans are secured by the balances in the participants' accounts and bear interest at rates ranging from 4.25 percent to 9.50 percent, which rates were commensurate with prevailing rates at the time of loan origination. Principal and interest are paid ratably through payroll deductions. Loans are re-paid over a five-year period, unless the loans were used to purchase a principal residence, in which case the payback period may not exceed 30 years. As of December 31, 2025, the Plan had outstanding loans to participants with maturities ranging from 2026 through 2054.

6. <u>Benefits paid to participants</u>

On termination of service due to death, permanent disability, or retirement, a participant or beneficiary may receive a lump-sum amount equal to the value of the participant's vested interest in his or her account. For termination of service due to other reasons, the Plan will automatically make a lump-sum distribution of the value of the participant's vested interest in his or her account where the account balance is less than $7,000. Hardship withdrawals are allowed for participants incurring a "specific and heavy financial need," as defined by the Plan. Hardship withdrawals are strictly regulated under the Internal Revenue Code and the regulations thereunder, and a participant must exhaust all available loan options and available distributions prior to requesting a hardship withdrawal.

7. <u>Forfeited accounts</u>

Forfeited accounts related to the Company's matching contributions may be used to pay any administrative expenses or used to reduce any future Employer matching contributions. The table below provides a reconciliation of the balance of forfeited accounts as of and for the year ended December 31, 2025.

---

| | |
|:---|:---|
| Balance as of December 31, 2024 | $174187 |
| &nbsp;&nbsp;Forfeitures | 65840 |
| &nbsp;&nbsp;Employer matching contributions | (172468) |
| &nbsp;&nbsp;Earnings on forfeited account balance | 3997 |
| &nbsp;&nbsp;Administrative expenses | (42087) |
| Balance as of December 31, 2025 | $29469 |

---

During the year ended December 31, 2025, $172,468 of forfeitures were used to reduce Employer matching contributions and $42,087 forfeitures were used to pay administrative expenses.

8. <u>Expenses</u>

The Company, as the Plan Sponsor, pays certain administrative expenses of the Plan. The expenses paid by Plan participants or from the forfeiture account totaled $218,116, which are reflected on the Statement of Changes in Net Assets Available for Benefits for the year ended December 31, 2025.

**NOTE B** – **SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**

1. <u>Basis of accounting</u>

The financial statements of the Plan are presented using the accrual method of accounting in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").

2. <u>Use of estimates</u>

The preparation of financial statements in conformity with U.S. GAAP requires Plan management to make estimates and assumptions that affect certain reported amounts of net assets available for benefits at the date of the financial statements, the changes in net assets available for benefits during the reporting period and, when applicable, the disclosure of contingent assets and liabilities at the date of the financial statements. Key estimates include determination of the fair value of investments. Actual results may differ from estimates and assumptions made.

------

3. <u>Investment valuation and income recognition</u>

The Plan's investments are stated at fair value. Quoted market prices are used to value investments in shares of mutual funds and the Stock Fund. Units of the collective investment fund are valued at net asset value, which approximates fair value, using daily market information. Net appreciation (depreciation) caused by fluctuations in the value of investments is reflected in the statement of changes in net assets available for benefits. Amounts invested may earn interest and dividends, which in turn are reinvested.

Purchases and sales of securities are recorded on a trade-date basis. Income from interest is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. Earnings and losses within each fund are allocated to participants based on their proportionate shares in the fund.

In general, the Plan's securities are exposed to various risks, such as interest rate, credit, and overall market volatility. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the accompanying statements of net assets available for benefits.

4. <u>Notes receivable from participants</u>

Notes receivable from participants represent participant loans and are valued at their unpaid principal balance plus any accrued but unpaid interest, which approximates fair value. As of December 31, 2025 and December 31, 2024, no allowances for credit losses had been recorded. If a participant ceases to make loan repayments and the Plan Administrators deem the note receivable from a participant to be a distribution, the note receivable balance is reduced and a benefit payment is recorded.

5. <u>Benefits paid to participants</u>

Benefits are recorded when paid. As of December 31, 2025 and December 31, 2024, there were no distributions that had been requested but not paid.

6. <u>Subsequent events</u>

Plan management has evaluated events occurring subsequent to year-end through June 12, 2026, which is the date the financial statements were available to be issued.

**NOTE C** – **FAIR VALUE MEASUREMENTS**

The Plan reports investments in accordance with established authoritative guidance, which requires a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date.

The three levels are defined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

 ● Level 1 inputs are quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

 ● Level 2 inputs are from other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

 ● Level 3 inputs are unobservable and are used to measure fair value in situations where there is little, if any, market activity for the asset or liability at the measurement date.

Mutual funds are valued at the total market value of the underlying assets based upon the publicly quoted price of each fund multiplied by the respective number of units held as of the measurement date and are classified as Level 1 investments.

The Stock Fund is a unitized stock fund consisting primarily of the Company's common stock, and cash for daily liquidity purposes. The Stock Fund is classified as Level 1, as the total fair value is equal to the quoted market value of total common stock plus the carrying amount of cash, which approximates fair value. The cash balance held by the Plan was $1,038 and $1,068 as of December 31, 2025 and December 31, 2024, respectively.

------

In accordance with Subtopic 820-10, the collective investment fund is measured using the net asset value per unit as a practical expedient and is therefore not classified in the fair value hierarchy.

Redemption frequency for the collective investment fund is immediate, contains no unfunded commitments, and has no redemption restrictions.

**NOTE D** – **EXEMPT PARTY-IN-INTEREST TRANSACTIONS**

Plan assets include common stock of the Company. Transactions with respect to shares of the Company's common stock qualify as party-in-interest transactions. As of December 31, 2025 and December 31, 2024, the Plan held 67,114 shares of the Company's common stock in the Stock Fund with a value of $19.63 per share, and 68,577 shares of the Company's common stock in the Stock Fund with a value of $35.89 per share, respectively.

Notes receivable from participants as of December 31, 2025 and December 31, 2024, were $2,284,606 and $2,400,566, respectively. Notes receivable are considered party-in-interest transactions. Interest income pertaining to notes receivable from participants totaled $188,179 for 2025.

Certain Plan investments are shares in registered investment company funds managed by Fidelity Investments, an affiliate of the Trustee as defined by the Plan, and therefore, these transactions qualify as party-in-interest transactions.

**NOTE E** – **PLAN TERMINATION**

Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue the Company's contributions at any time and to terminate the Plan subject to the provisions of ERISA. In the event of Plan termination, participants become 100 percent vested in their accounts.

**NOTE F – TAX STATUS** 

The Plan has adopted a non-standardized prototype plan for which the Internal Revenue Service ("IRS") has issued a favorable opinion letter covering the qualification of the Plan. The Plan Administrators and the Plan's tax counsel do not anticipate that changes in the Plan after the date of the IRS opinion letter will affect the qualified and tax-exempt status of the Plan. Accordingly, the financial statements of the Plan do not include provisions, assets or liabilities related to income taxes.

U.S. GAAP requires management to evaluate income tax positions taken by the Plan and to recognize an income tax liability if the Plan has taken an uncertain tax position that more likely than not would not be sustained upon examination by taxing authorities. The Plan Administrators analyzed the tax positions taken by the Plan and have concluded that as of December 31, 2025 and December 31, 2024, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the financial statements. The Plan is subject to routine audits by tax jurisdictions for tax years for which the applicable statutes of limitations have not expired; however, there are currently no audits for any tax periods in progress.

------

**USANA HEALTH SCIENCES 401(k) PLAN**

**SUPPLEMENTAL INFORMATION**

Employer Identification Number: 87-0500306

Plan Number: 001

SCHEDULE H, PART IV, Line 4(i)

SCHEDULE OF ASSETS (HELD AT END OF YEAR)

As of December 31, 2025

---

| | | | | |
|:---|:---|:---|:---|:---|
| (a) | (b) | (c) | (d) | (e) |
|  | IDENTITY OF ISSUE, BORROWER, LESSOR, OR SIMILAR PARTY | DESCRIPTION OF INVESTMENT | COST | CURRENT VALUE |
| \* | Fidelity® 500 Index Fund | Mutual funds | \*\* | $25598120 |
| \* | Fidelity® Large Cap Growth Index Fund | Mutual funds | \*\* | 14134252 |
|  | American Funds 2050 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 13955883 |
|  | American Funds 2045 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 9550146 |
|  | American Funds 2040 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 9459226 |
|  | MFS International Growth Fund Class R6 | Mutual funds | \*\* | 6920441 |
|  | American Funds 2035 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 6842221 |
|  | American Funds 2055 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 6777291 |
|  | American Funds 2030 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 5459873 |
|  | PGIM Total Return Bond Fund Class R-6 | Mutual funds | \*\* | 4764323 |
|  | American Funds American Balanced Fund® Class R-6 | Mutual funds | \*\* | 4251315 |
|  | American Funds 2060 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 2958204 |
| \* | Fidelity® Mid Cap Index Fund | Mutual funds | \*\* | 2851989 |
| \* | Fidelity® Small Cap Index Fund | Mutual funds | \*\* | 2643309 |
|  | American Funds New World Fund® Class R-6 | Mutual funds | \*\* | 2153135 |
|  | Carillon Eagle Mid Cap Growth Fund Class R-6 | Mutual funds | \*\* | 1850842 |
|  | Janus Henderson Triton Fund Class I | Mutual funds | \*\* | 1402735 |
|  | Victory Sycamore Established Value Fund Class R-6 | Mutual funds | \*\* | 1398089 |
| \* | Fidelity® Total International Index Fund | Mutual funds | \*\* | 1158748 |
|  | American Funds 2025 Target Date Retirement Income Fund Class R-6 | Mutual funds | \*\* | 1119518 |
|  | Principal Real Estate Securities Fund Institutional Class | Mutual funds | \*\* | 1026002 |
|  | Undiscovered Managers Behavioral Value Fund Class L | Mutual funds | \*\* | 988232 |
|  | American Funds 2020 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 253741 |
|  | PIMCO Income Fund Institutional Class | Mutual funds | \*\* | 30534 |
| \* | Fidelity® Government Money Market Fund | Mutual funds | \*\* | 21217 |
|  | American Funds 2010 Target Date Retirement Fund® Class R-6 | Mutual funds | \*\* | 11067 |
|  | American Funds 2015 Target Date Retirement Income Fund Class R-6 | Mutual funds | \*\* | 8957 |
|  |  |  |  | 127589410 |
| \* | USANA Health Sciences, Inc. Stock Fund | Stock Fund | \*\* | 1318480 |
|  | Galliard Stable Return Fund C | Collective investment fund | \*\* | 7305763 |
| \* | Notes receivable from participants | Loans with interest rates ranging from 4.25% to 9.50%, with maturities through 2054 | N/A | 2284606 |
|  |  |  |  | $138498259 |
| \* | Party-in-interest |  |  |  |
| \*\* | Column (d) cost information is not presented as these investments are participant directed. |  |  |  |
|  | See accompanying Report of Independent Registered Public Accounting Firm. |  |  |  |

---

------

**<u>EXHIBIT</u>**

---

| | |
|:---|:---|
| **Exhibit**<br>**<u>Number</u>** | **<u>Description</u>** |
| 23.1 | <u>[Consent of Independent Registered Public Accounting Firm (filed herewith)](exhibit231-202511xk.htm)</u> |

---

------

**<u>SIGNATURE</u>**

*The Plan.* Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 12, 2026

---

| |
|:---|
| USANA Health Sciences 401(k) Plan |
| /s/ G. Douglas Hekking |
| G. Douglas Hekking |
| Chief Financial Officer<br>(Principal Financial and Accounting Officer)<br>Plan Sponsor |

---

## Exhibit 23.1

**Exhibit 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in Registration Statement No. 333-128103 on Form S-8 of our report dated June 12, 2026, appearing in this Annual Report on Form 11-K of the USANA Health Sciences 401(k) Plan for the year ended December 31, 2025.

/s/ Tanner LLP

Salt Lake City, Utah<br>June 12, 2026

<br>